- Lobbying
- phrma
Lobbying Arrangements Results for 'Phrma'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details ADVOCATE POLICIES ENSURING INTEGRITY OF PHARMACEUTICAL SUPPLY CHAIN |
PhRMA
|
B & D CONSULTING | |||
Details Patent reform regarding pharmaceutical research & products. |
PhRMA
|
HANCE SCARBOROUGH | |||
Details Support PhRMA issues. |
PhRMA
|
Ice Miller Strategies LLC | |||
Details Issues that effect medical innovation, including Medicare, Trade Issues, health care funding. |
PhRMA (on behalf of We Work for Health)
|
Perry, White, Ross & Jacobson, LLC | |||
Details Independent Patient Advisory Board (IPAB) and Medicare Part D |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
G. Fox Consulting | |||
Details Improving health and lowering health care costs through prevention and management of chronic disease. |
PhRMA o/b/o Partnership to Fight Chronic Disease formerly o/b/o CAMI & PFCD
|
Policy Breakthroughs LLC | |||
Details Medicare, Medicaid, PDUFA and Patent Reform |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Mr. Derrick White | |||
Details Implementation of PL 111-148, The Patient Protection and Affordable Care Act and the economic impact of budget cuts to biopharmaceuticals. |
PhRMA on behalf of We Work for Health
|
TKG Federal Affairs | |||
Details Implementation of the Patient Protection and Affordable Care Act; Issues related to government efforts to roll out the COVID vaccination system. Discussions surrounding pending tax related provisio... |
PhRMA (on behalf of We Work for Health)
|
Capitol Legislative Strategies LLC | |||
Details General legislation pertaining to healthcare issues |
PHARMACEUTICAL RESEARCH ASSN (PHRMA)
|
ABERNATHY CONSULTANTS, CATHY | |||
Details Generally concerned about issues that effect medical innovation, including Medicare, Trade Issues, health care funding. |
PhRMA (on behalf of We Work for Health)
|
Rifkin, Livingston, Levitan & Silver, LLC | |||
Details Trade Policy in Latin America |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
FTI Government Affairs | |||
Details Medicare D |
PhRMA (on behalf of We Work for Health )
|
Capitol Strategies Group, LLC | |||
Details FY 2024 Appropriations bills |
SL Strategies, LLC (On behalf of PhRMA)
|
LKB STRATEGIES LLC | |||
Details Position on Price Controls; Patent Protections, Illegal Importation of Biopharmaceuticals. |
PhRMA
|
Mr. Vincent A. Panvini | |||
Details COVID R&D, Medicare Part D, drug pricing |
PhRMA, on behalf of We Work For Health
|
Bose Public Affairs Group | |||
Details PBM Reform IRA implementation Non-interference Rebate reforms Innovation economy Research & Development funding |
PhRMA
|
CONVERGENCE PUBLIC AFFAIRS LLC | |||
Details - Non-interference - Drug importation - Medicare Parts B & D - Price controls - International Pricing Index |
PhRMA on behalf of We Work for Health
|
Howard Consulting Group, Inc. | |||
Details Any federal issues regarding the research and development of pharmaceuticals |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Dentons US LLP | |||
Details Health care reform issues affecting the pharmaceutical industry. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
PRICEWATERHOUSECOOPERS | |||
Details Healthcare issues |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Wheat Government Relations | |||
Details HR3 Lower Drug Costs Now Act |
PhRMA
|
The Strategy Group, Inc. | |||
Details Issues related to federal health care programs and health litigation. |
PhRMA
|
Dentons US LLP | |||
Details Health care reform, in particular biosimilars. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Ms. Rebecca Halkias | |||
Details Issues related to The Patient Protection and Affordable Care Act (Public Law 111 148) |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
WHITMER & WORRALL, LLC | |||
Details Price Controls, Intellectual Property Rights S.127 S.113 S.1339 |
PhRMA
|
The Mathis Harple Group | |||
Details Medicaid & Medicare COVID-19 Research and development of biopharmaceuticals Economic impact of the biopharmaceutical industry Research and development of biopharmaceuticals Inflation Reduction Act |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
KLINK CAMPAIGNS, INC | |||
Details Ensuring adequate and effective intellectual property rights for pharmaceutical products in non-U.S. markets. |
The Pharmaceutical Research and Manufacturers of America (PhRMA)
|
CROWELL & MORING LLP | |||
Details The protection of Medicare Part D, issues around IP protection, and the impact of pharmaceuticals on the economy. |
DDC Advocacy (on behalf of PhRMA / We Work For Health)
Public Affairs Firm (On behalf of coalition representing Pharma/ Biotech firms in the US) |
LIBERTY SQUARE GROUP | |||
Details HR 9 and any other legislation regarding patent law reform. |
Pharmaceutical Research and Manufactureres of America (PhRMA)
|
MCKENNA, LONG & ALDRIDGE | |||
Details Promotion of chronic disease prevention and treatment incentives in healthcare reform. |
PhRMA (on behalf of Partnership to Fight Chronic Disease)
|
Lesic & Camper Communications LLC | |||
Details Foreign Reference Pricing, Anti-Microbial Resistance, Access to Prescription Drugs, Innovation, Vaccines |
PhRMA(on behalf of We Work for Health)
|
Randolph E. Cloud & Associates | |||
Details H.R. 380, Drug Importation Act, provisions concerning increasing the importation of prescription drugs from foreign countries into the United States |
PhRMA
pharmaceutical research and biotechnology |
MADISON SERVICES GROUP, INC. | |||
Details Monitor health care legislation and regulations |
PhRMA
Pharmaceutical Association |
The Roth Group | |||
Details Hispanic health outreach |
Pharmaceutical Research and Manufacturers Association (PHRMA)
Represents the country's leading pharmaceutical research and biotechnology companies |
Mickey Ibarra & Associates | |||
Details Issues related to access to bio-pharmaceuticals. |
PhRMA
|
VENN STRATEGIES | |||
Details Medicare Part D, Prescription Drug Program |
Pharmaceutical Research and Manufacturers of America
|
Prime Policy Group | |||
Details Work to protect patent protections for pharmaceutical companies and other general issues relating to the Pharmaceutical Industry Work to protect patent protections for pharmaceutical companies and ... |
PhRMA
|
Nelson, Mullins, Riley & Scarborough | |||
Details Monitoring healthcare and drug pricing discussions, including implementation of the Inflation Reduction Act of 2022, H.R.5376, P.L.117-169. Issues related to policies concerning the pharmaceutical ... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
The Simmons & Russell Group, LLC | |||
Details Issues related to international trade; nominations to USTR and Commerce Issues related to intellectual property |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
TIGER HILL PARTNERS LLC | |||
Details water quality legislation, S.1005 patent law, S.515, H.R. 1260 |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
THE ACCORD GROUP | |||
Details FY17 Appropriations Bills |
Pharmaceutical Research and Manufacturers of America
Pharmaceutical association. |
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details Chronic disease prevention and management within the Senate HELP Committee's "Affordable Health Choices Act," and the Senate Finance Committee's "America's Healthy Futures Act of 2009. Follow-on B... |
PhRMA (on behalf of We Work for Health and Partnership to Fight Chronic Disease)
|
Public Affairs Company | |||
Details U.S. Assistance for Global HIV/AIDS Programs |
PhRMA
|
THE WHITAKER GROUP, LLC | |||
Details Integrity of Medicare Part D Medicare Part B and the Affordable Care Act Public Law No: 111-148; H.R. 3 - Lower Drug Costs Now Act |
PhRMA, (on behalf of We Work For Health)
|
Junto Solutions, LLC | |||
Details Patent Reform |
PhRMA
Represents the country’s leading pharmaceutical research and biotechnology companies |
NUEVA VISTA GROUP, LLC. | |||
Details Patent Reform Issues Non-interference in Part D Drug Negotiation |
PhRMA
Pharmaceutical Trade Association |
Quinn Gillespie & Associates | |||
Details Encouraged Congress and Executive Branch to insist that foreign countries implement their obligations under the WTO TRIPS Agreement and other international and bilateral intellectual property agree... |
PHRMA
|
THE GORLIN GROUP | |||
Details Trans-Pacific Partnership |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Hogan Lovells US LLP | |||
Details Issues related to Medicare Part D; issues related to the drug industry, issues related to comparative effectiveness, issues related to follow-on biologics; issues related to the Independent Payment... |
Cauthen Forbes & Williams on behalf of PhRMA
|
Forbes-Tate |